June 16, 2021

Volume XI, Number 167

Advertisement

June 16, 2021

Subscribe to Latest Legal News and Analysis

June 15, 2021

Subscribe to Latest Legal News and Analysis

June 14, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
10
Jun
China on the Move: An Improving Regulatory Landscape with New Challenges Ahead – Genomics and National Security Greenberg Traurig, LLP
9
Jun
Video: Leaders Moving Business Forward with Peter Mason of UNICEF McDermott Will & Emery
9
Jun
HHS Issues Buprenorphine Practice Guidelines as Study Confirms Access Barriers Mintz
9
Jun
General Mills Flavor Labeling Settlement Denied Keller and Heckman LLP
9
Jun
Montana Will Protect Off-Duty Use of Marijuana Next Year Jackson Lewis P.C.
8
Jun
Mexico Amends the Health Law Regulations with Impact in the Approval of Medicines OLIVARES
8
Jun
Lawsuit Takes Aim at “Natural” Claims in Dog Shampoos Keller and Heckman LLP
8
Jun
New Class Action Litigation Claims That Fish Oil Is The Modern-Day Snake Oil Epstein Becker & Green, P.C.
8
Jun
New Era for Insects! Keller and Heckman LLP
7
Jun
L’Occitane’s 9 Million RMB Award for Trademark Infringement in China Affirmed on Appeal Schwegman, Lundberg & Woessner, P.A.
7
Jun
FDA’s Unapproved Drugs Initiative Revived, with Gusto! Mintz
7
Jun
ANSES Reiterates Recommendation to Restrict Use of Products Containing Nanomaterials “That Are of Little Benefit to the Population” Bergeson & Campbell, P.C.
7
Jun
Class-Action Alleges Protein Content in Purely Elizabeth Products Overstated Keller and Heckman LLP
4
Jun
The FTC, CIDs and the Opioid Addiction Recovery Fraud Prevention Act Hinch Newman LLP
4
Jun
EUON Publishes Nanopinion on the Need for Updating Language Regarding Nanomaterials Bergeson & Campbell, P.C.
4
Jun
Class Actions Continue to Target Butter & Vanilla Keller and Heckman LLP
4
Jun
PFAS Paper Mill Lawsuit Adds Additional Companies CMBG3 Law
4
Jun
EEOC Updates Guidance on COVID-19 Vaccination Policies, Including Mandates, Incentives, and Accommodations Epstein Becker & Green, P.C.
4
Jun
FDA Ban On PFAS In Food Packaging Brought To Forefront CMBG3 Law
4
Jun
Titanium Dioxide: An Unexpected Decision from EFSA Keller and Heckman LLP

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement